These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18211982)

  • 21. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
    Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy.
    Xu X; Wang Z; Jiang S; Shang Y; Wu Y
    Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
    Chen G; Wang Z; Liu XY; Liu FY
    Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
    Higuchi I; Yasuda T; Yano M; Doki Y; Miyata H; Tatsumi M; Fukunaga H; Takiguchi S; Fujiwara Y; Hatazawa J; Monden M
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):205-12, 212.e1-3. PubMed ID: 18603077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes and prognostic factors for patients with esophageal cancer following radiotherapy.
    Chen CZ; Chen JZ; Li DR; Lin ZX; Zhou MZ; Li DS; Chen ZJ
    World J Gastroenterol; 2013 Mar; 19(10):1639-44. PubMed ID: 23539205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of circumferential resection margin status on loco-regional recurrence in esophageal squamous cell carcinoma.
    Park HJ; Kim HJ; Chie EK; Kang CH; Kim YT
    J Surg Oncol; 2013 Jun; 107(7):762-6. PubMed ID: 23280705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective, open, multicentre Phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and cisplatin for esophageal carcinoma.
    Ma HB; Di ZL; Wen J; Ke Y; Sun X; Ren J
    Jpn J Clin Oncol; 2015 Feb; 45(2):169-75. PubMed ID: 25416813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial.
    Tachibana M; Yoshimura H; Kinugasa S; Shibakita M; Dhar DK; Ueda S; Fujii T; Nagasue N
    Eur J Surg Oncol; 2003 Sep; 29(7):580-7. PubMed ID: 12943623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study.
    Jingu K; Matsushita H; Takeda K; Umezawa R; Takahashi C; Sugawara T; Kubozono M; Abe K; Tanabe T; Shirata Y; Yamamoto T; Ishikawa Y; Nemoto K
    BMC Cancer; 2012 Nov; 12():542. PubMed ID: 23171077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
    Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
    Chen J; Yin W; Yao H; Gu W
    Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
    Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
    World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Factors affecting on long-time survival in patients with stage Ⅲ thoracic esophageal carcinoma after esophagectomy].
    Yang Q; Wang YX; He M; Li J; Qi Z; Zhu SC; Qiao XY
    Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):530-7. PubMed ID: 27531268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
    Depypere L; Lerut T; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P; Nafteux P
    Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 27704661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the 7th and 8th editions of the American Joint Committee on Cancer/Union for International Cancer Control TNM staging system for esophageal squamous cell carcinoma treated by definitive radiotherapy.
    Inada M; Nishimura Y; Ishikawa K; Nakamatsu K; Wada Y; Uehara T; Fukuda K; Anami S; Doi H; Kanamori S
    Esophagus; 2019 Oct; 16(4):371-376. PubMed ID: 31111308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma.
    Lew JI; Gooding WE; Ribeiro U; Safatle-Ribeiro AV; Posner MC
    Arch Surg; 2001 Jul; 136(7):737-42; discussion 743. PubMed ID: 11448381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Esophageal cancer: outcome according to therapeutic strategy].
    Rousseau D; Capitain O; Denis F; Girault S; Poirier AL; Paumier A; Cellier P; Hamy A; Mahé MA; Mesgouez-Nebout N
    Cancer Radiother; 2013 Feb; 17(1):10-20. PubMed ID: 23270680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation therapy for loco-regionally recurrent esophageal cancer after surgery.
    Nemoto K; Ariga H; Kakuto Y; Matsushita H; Takeda K; Takahashi C; Takai Y; Yamada S; Hosoi Y
    Radiother Oncol; 2001 Nov; 61(2):165-8. PubMed ID: 11690682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer.
    Vermund H; Pories WJ; Hillard J; Wiley AL; Youngblood R
    Acta Oncol; 2001; 40(5):558-65. PubMed ID: 11669326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline nutritional status is prognostic factor after definitive radiochemotherapy for esophageal cancer.
    Clavier JB; Antoni D; Atlani D; Ben Abdelghani M; Schumacher C; Dufour P; Kurtz JE; Noel G
    Dis Esophagus; 2014 Aug; 27(6):560-7. PubMed ID: 23106980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.